MK
Mitchell Kapoor HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
182
Avg Return
Past Year
Past Year
7%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
82.1%
Neutral
12.6%
Negative
5.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $40 |
331%
upside
| 5 | -13% |
0
%
| 9 Apr ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| – | – | 8 | -15% |
0
%
| 9 Apr ‘25 6 months ago |
|
|
|
Buy
Maintained
| $2 |
254%
upside
| 3 | -20% |
0
%
| 3 Apr ‘25 6 months ago |
|
|
|
Buy
Reiterated
| $9 |
216%
upside
| 2 | +36% |
0
%
| 3 Apr ‘25 6 months ago |
|
|
|
Buy
Reiterated
| $15 |
174%
upside
| 2 | -2.9% |
0
%
| 24 Mar ‘25 7 months ago |
|
|
|
Neutral
Downgraded
| – | – | 2 | -51% |
0
%
| 16 Dec ‘24 10 months ago |
|